Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avinger Inc
(NQ:
AVGR
)
3.900
+0.060 (+1.56%)
Streaming Delayed Price
Updated: 3:47 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avinger Inc
< Previous
1
2
3
Next >
Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication
July 06, 2021
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Exposures
Product Safety
Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany
June 28, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 28, 2021 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
June 07, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Announces Issuance and Allowance of Seven U.S. Patents
May 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26
May 17, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
Avinger Reports First Quarter 2021 Financial Results
May 06, 2021
13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage...
From
Avinger, Inc.
Via
AccessWire
Exposures
COVID-19
Avinger to Announce First Quarter 2021 Results on May 6, 2021
April 26, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
New Publications Highlight Clinical Benefits of Avinger PAD Therapies
April 21, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV
April 15, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...
From
Avinger, Inc.
Via
AccessWire
Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools
April 14, 2021
Via
FinancialNewsMedia
Avinger Provides Update on Tigereye(TM) Commercial Launch
April 08, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
From
Avinger, Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.